Impact of c-erbB-2 on Ovarian Cancer Cell Growth
Author Information
Author(s): Wiechen K, Karaaslan S, Turzynski A, Dietel M
Primary Institution: Institute of Pathology, Universitätsklinikum Charité, Medizinische Fakultät der Humboldt-Universität Berlin
Hypothesis
Does the suppression of the c-erbB-2 gene product affect the transformation abilities of SK-OV-3 ovarian cancer cells?
Conclusion
The c-erbB-2 oncogene enhances the transformation abilities of SK-OV-3 ovarian cancer cells without affecting their proliferation or secretion of proteases in high serum conditions.
Supporting Evidence
- The overexpression of c-erbB-2 is found in 20-30% of ovarian cancers.
- c-erbB-2 expression provides a growth advantage under low serum conditions.
- Cells expressing the c-erbB-2 antibody could not grow anchorage-independently.
Takeaway
This study found that a specific protein in ovarian cancer cells helps them grow better, but it doesn't change how fast they multiply or how much of certain substances they release.
Methodology
The study involved expressing a c-erbB-2-specific single-chain antibody in SK-OV-3 cells and comparing their growth and secretion characteristics.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website